(Q39269522)

10 September 2017

Tiagabine for posttraumatic stress disorder: effects of open-label and double-blind discontinuation treatment (English)

1 reference

10 September 2017

Kathryn M Connor

1

1 reference

10 September 2017

Jonathan R T Davidson

2

1 reference

10 September 2017

Richard H Weisler

3

1 reference

10 September 2017

Wei Zhang

4

1 reference

10 September 2017

Kurian Abraham

5

1 reference

10 September 2017

10 December 2005

1 reference

10 September 2017

1 reference

10 September 2017

184

1 reference

10 September 2017

21-25

1 reference

10 September 2017

1

1 reference

https://scigraph.springernature.com/pub.10.1007/s00213-005-0265-3

10 September 2017

0 references

cites work

Fluoxetine versus placebo in posttraumatic stress disorder.

1 reference

12 December 2020

Fluoxetine in post-traumatic stress disorder. Randomised, double-blind study

1 reference

12 December 2020

Efficacy of sertraline in preventing relapse of posttraumatic stress disorder: results of a 28-week double-blind, placebo-controlled study

1 reference

12 December 2020

Paroxetine in the treatment of chronic posttraumatic stress disorder: results of a placebo-controlled, flexible-dosage trial

1 reference

12 December 2020

The gamma-aminobutyric acid (GABA) uptake inhibitor, tiagabine, increases extracellular brain levels of GABA in awake rats.

1 reference

12 December 2020

Valproate therapy for chronic, combat-induced posttraumatic stress disorder

1 reference

12 December 2020

Maintenance therapy with fluoxetine in posttraumatic stress disorder: a placebo-controlled discontinuation study

1 reference

12 December 2020

Tiagabine for posttraumatic stress disorder: a case series of 7 women.

1 reference

12 December 2020

GABAB receptors: a new paradigm in G protein signaling

1 reference

12 December 2020

The diversity of GABAA receptors. Pharmacological and electrophysiological properties of GABAA channel subtypes

1 reference

12 December 2020

Variations on an inhibitory theme: phasic and tonic activation of GABA(A) receptors

1 reference

12 December 2020

Open-label topiramate as primary or adjunctive therapy in chronic civilian posttraumatic stress disorder: a preliminary report.

1 reference

12 December 2020

The Mini-International Neuropsychiatric Interview (M.I.N.I.): the development and validation of a structured diagnostic psychiatric interview for DSM-IV and ICD-10

1 reference

12 December 2020

Efficacy and safety of paroxetine treatment for chronic PTSD: a fixed-dose, placebo-controlled study

1 reference

12 December 2020

The hospital anxiety and depression scale

1 reference

12 December 2020

Reduced benzodiazepine sensitivity in patients with premenstrual syndrome: a pilot study.

1 reference

12 December 2020

Characterizing the effects of sertraline in post-traumatic stress disorder

1 reference

12 December 2020

SPRINT: a brief global assessment of post-traumatic stress disorder

1 reference

12 December 2020

Central type benzodiazepine receptors in Gulf War veterans with posttraumatic stress disorder

1 reference

12 December 2020

Preliminary study of carbamazepine in post-traumatic stress disorder

1 reference

12 December 2020

Low ethanol concentrations selectively augment the tonic inhibition mediated by delta subunit-containing GABAA receptors in hippocampal neurons.

1 reference

12 December 2020

Treatment of posttraumatic stress disorder with tiagabine

1 reference

12 December 2020

Remission in post-traumatic stress disorder (PTSD): effects of sertraline as assessed by the Davidson Trauma Scale, Clinical Global Impressions and the Clinician-Administered PTSD scale

1 reference

12 December 2020

Decreased benzodiazepine receptor binding in prefrontal cortex in combat-related posttraumatic stress disorder

1 reference

12 December 2020

Ethanol enhances alpha 4 beta 3 delta and alpha 6 beta 3 delta gamma-aminobutyric acid type A receptors at low concentrations known to affect humans

1 reference

12 December 2020

Pilot evaluation of hypnotic medication during acute traumatic stress response.

1 reference

12 December 2020

Development of a new resilience scale: the Connor-Davidson Resilience Scale (CD-RISC).

1 reference

12 December 2020

GABA transporter deficiency causes tremor, ataxia, nervousness, and increased GABA-induced tonic conductance in cerebellum.

1 reference

12 December 2020

Structured interview for PTSD (SIP): psychometric validation for DSM-IV criteria

1 reference

12 December 2020

Multicenter, double-blind comparison of sertraline and placebo in the treatment of posttraumatic stress disorder

1 reference

12 December 2020

Assessment of a new self-rating scale for post-traumatic stress disorder

1 reference

12 December 2020

Sertraline treatment of posttraumatic stress disorder: results of 24 weeks of open-label continuation treatment

1 reference

12 December 2020

Symptom-specific effects of fluoxetine in post-traumatic stress disorder

1 reference

12 December 2020

Distinguishing between GABA(A) receptors responsible for tonic and phasic conductances

1 reference

12 December 2020

Posttraumatic stress disorder in vietnam veterans clinical and EEG findings; possible therapeutic effects of carbamazepine

1 reference

12 December 2020

The Pittsburgh Sleep Quality Index: a new instrument for psychiatric practice and research

1 reference

12 December 2020

Efficacy and safety of sertraline treatment of posttraumatic stress disorder: a randomized controlled trial

1 reference

12 December 2020

Effects of the benzodiazepine antagonist flumazenil in PTSD

1 reference

12 December 2020

Valproate in combat-related posttraumatic stress disorder.

1 reference

12 December 2020

Alcohol effects on gamma-aminobutyric acid type A receptors: are extrasynaptic receptors the answer?

1 reference

12 December 2020

Fluoxetine v. placebo in prevention of relapse in post-traumatic stress disorder

1 reference

12 December 2020

Treatment of recent trauma survivors with benzodiazepines: a prospective study.

1 reference

12 December 2020

Core symptoms of posttraumatic stress disorder unimproved by alprazolam treatment

1 reference

12 December 2020

Divalproex in posttraumatic stress disorder: an open-label clinical trial

1 reference

12 December 2020

10.1007/S00213-005-0265-3

Identifiers

DOI

1 reference

release_yclmaq6kkra5pj5mdxrlcbfuqu

10 September 2017

0 references

1 reference